A Study of CI-1012 in HIV-Infected Patients

Inclusion Criteria Patients must have: * Serologic evidence of infection with HIV-1. * CD4+ cell count \>= 200 cells/mm3. * HIV-1 RNA \>= 10,000 copies/ml. Exclusion Criteria Co-existing Condition: Patients with the following conditions are excluded: Viral, fungal, or bacterial infection requiring therapy other than topical medications. Concurrent Medication: Excluded: * Prophylactic systematic antibacterial, antifungal or antiviral agents. * Antiretroviral therapy. NOTE: * Patient must be willing to remain off antiretroviral therapy for 1 week after completing study medication. Prior Medication: Excluded: * Experimental therapy for \>= 4 weeks prior to initiation of study medication. * Antiretroviral treatment for 3 weeks prior to initiation of study medication. * Systemic steroids or anticancer agents for 4 weeks prior to initiation of study medication.